Catheter ablation of atrial fibrillation combined with dronedarone as a new hybrid therapy option

Trial Profile

Catheter ablation of atrial fibrillation combined with dronedarone as a new hybrid therapy option

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2012

At a glance

  • Drugs Dronedarone (Primary) ; Amiodarone; Antiarrhythmics; Flecainide
  • Indications Atrial fibrillation; Paroxysmal atrial fibrillation
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Sep 2012 New trial record
    • 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top